Shares of the company, which has been investing heavily in its skincare segment as more consumers opt for products like serums, toners and face masks, rose nearly 5% in premarket trading.

Sales in the skincare business, its biggest and most profitable segment, rose 15% to $1.59 billion in the fourth quarter, while sales in Asia-Pacific region, which includes China, grew 18%.

The company said it expects full-year sales to grow in the range of 7% to 8% and adjusted profit to be between $5.90 and $5.98 per share in fiscal 2020. Analysts had expected a sales growth of 6.87% and profit of $5.81 per share.

The company said its forecast takes into account geopolitical issues such as Hong Kong protests, costs related to Britain's impending exit from the European Union and the escalating trade dispute between the United States and China.

Net earnings attributable to the company fell to $157 million, or 43 cents per share, in the quarter ended June 30, from $186 million, or 49 cents per share, a year earlier

Excluding items, it earned 64 cents per share, beating the average analyst estimate of 53 cents per share.